Company intelligence / Profile preview

tp21

Berlin, Berlin, Germany

Ownership: Private
Development stage: Other

Overview

tp21 specializes in project management and consultancy for interdisciplinary research projects, multi-center clinical trials, and technology transfer initiatives, with a strong focus on data transparency, clinical trial disclosure, and supporting digital health and AI-driven healthcare innovation. The company manages large-scale EU-funded projects such as TEF‑Health (AI & robotics for health) and dAIbetes (precision medicine in diabetes), but does not develop its own therapeutics or diagnostics[1][2][3].

Industry: Consulting

Partnerships

Charité – Universitätsmedizin Berlin (TEF‑Health project)University of Hamburg (dAIbetes project)Multiple European academic institutions via EU consortia

Beyond the preview

Go deeper on tp21.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on tp21.

Explore the full profile